Optimal MTX Dose With Folic Acid Randomized Case-control Trial

NCT04066803 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: MTX
DRUG: Folic Acid
DRUG: DMARDs

Sponsor

Sun Yat-sen University

Collaborators

[object Object]